Gyre Therapeutics, Inc. (GYRE)
4.21
-0.31
(-6.86%)
USD |
NASDAQ |
Nov 20, 16:00
4.21
0.00 (0.00%)
After-Hours: 20:00
Gyre Therapeutics Price to Book Value : 4.176 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 4.176 |
| November 19, 2026 | 4.483 |
| November 18, 2026 | 4.304 |
| November 17, 2026 | 4.523 |
| November 16, 2026 | 4.354 |
| November 13, 2026 | 4.275 |
| November 12, 2026 | 4.265 |
| November 11, 2026 | 4.225 |
| November 10, 2026 | 4.195 |
| November 09, 2026 | 4.612 |
| November 06, 2026 | 4.721 |
| November 05, 2026 | 3.977 |
| November 04, 2026 | 4.404 |
| November 03, 2026 | 4.404 |
| November 02, 2026 | 4.691 |
| October 30, 2026 | 4.518 |
| October 29, 2026 | 6.357 |
| October 28, 2026 | 7.032 |
| October 27, 2026 | 6.476 |
| October 26, 2026 | 6.020 |
| October 23, 2026 | 5.802 |
| October 22, 2026 | 5.812 |
| October 21, 2026 | 5.852 |
| October 20, 2026 | 6.119 |
| October 19, 2026 | 6.04 |
| Date | Value |
|---|---|
| October 16, 2026 | 6.030 |
| October 15, 2026 | 6.348 |
| October 14, 2026 | 6.417 |
| October 13, 2026 | 6.655 |
| October 12, 2026 | 6.809 |
| October 09, 2026 | 6.982 |
| October 08, 2026 | 6.705 |
| October 07, 2026 | 6.982 |
| October 06, 2026 | 7.022 |
| October 05, 2026 | 7.290 |
| October 02, 2026 | 7.052 |
| October 01, 2026 | 6.943 |
| September 30, 2026 | 7.270 |
| September 29, 2026 | 7.192 |
| September 28, 2026 | 7.359 |
| September 25, 2026 | 7.221 |
| September 24, 2026 | 7.201 |
| September 23, 2026 | 7.270 |
| September 22, 2026 | 7.359 |
| September 21, 2026 | 7.300 |
| September 18, 2026 | 7.418 |
| September 17, 2026 | 7.054 |
| September 16, 2026 | 6.582 |
| September 15, 2026 | 6.573 |
| September 14, 2026 | 6.573 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Incyte Corp. | 4.144 |
| ACADIA Pharmaceuticals, Inc. | 2.131 |
| Alnylam Pharmaceuticals, Inc. | 5.343 |
| Anika Therapeutics, Inc. | 1.288 |
| Savara, Inc. | 8.118 |
Price to Book Value Related Metrics
| PS Ratio | 3.366 |
| PEG Ratio | -0.0089 |
| Price | 4.21 |
| Earnings Yield | -6.39% |
| Market Cap | 450.76M |
| PEGY Ratio | -0.0089 |